Who owns NOVABAY PHARMACEUTICALS INC?
- Ticker: NBY
- CUSIP Number: 66987p409
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 85k | $108k | 100% | Sep 2025 |
|
| Geode Capital Management | 52k | $66k | 53% | Sep 2025 |
|
| State Street Corporation | 29k | $38k | 100% | Sep 2025 |
|
| Apollon Wealth Management | 28k | $35k | 100% | Sep 2025 |
|
| Ground Swell Capital | 19k | $25k | 100% | Sep 2025 |
|
| Virtu Financial | 11k | $14k | 100% | Sep 2025 |
|
| Tower Research Capital | 948.00 | $1.2k | -83% | Sep 2025 |
|
| Morgan Stanley | 3.00 | $2.000100 | 100% | Jun 2025 |
|
| NVWM | 3.00 | $3.999900 | 0% | Sep 2025 |
|
| Addison Advisors | 1.00 | $2.000000 | 0% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 1.00 | $1.000000 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 1.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Novabay Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| C2C Wealth Management | Jun 2025 | 98k | $57k |
| Rangeley Capital | Jun 2025 | 33k | $19k |
| Two Sigma Securities | Jun 2025 | 24k | $14k |
| XTX Topco | Jun 2025 | 20k | $12k |
| UBS Group | Jun 2025 | 3.4k | $2.0k |